We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+6.2%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$9.56B
AUM Growth
+$531M
(+5.9%)
Cap. Flow
+$49.6M
Cap. Flow
% of AUM
0.52%
Top 10 Holdings %
Top 10 Hldgs %
14.04%
Holding
1,755
New
15
Increased
420
Reduced
1,119
Closed
198
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Dynamics
GD
|
+$57.1M |
| 2 |
Federal Realty Investment Trust
FRT
|
+$54.9M |
| 3 |
New Jersey Resources
NJR
|
+$10.3M |
| 4 |
Medtronic
MDT
|
+$10.1M |
| 5 |
UMB Financial
UMBF
|
+$10M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Healthpeak Properties
DOC
|
+$48.2M |
| 2 |
CLC
Clarcor
CLC
|
+$15.4M |
| 3 |
Amgen
AMGN
|
+$11.3M |
| 4 |
Apple
AAPL
|
+$9.79M |
| 5 |
Nucor
NUE
|
+$8.91M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.52% |
| 2 | Healthcare | 14.53% |
| 3 | Technology | 12.08% |
| 4 | Consumer Staples | 11.47% |
| 5 | Industrials | 10.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Rigel Pharmaceuticals
RIGL
$681M
| $263K | ﹤0.01% |
7,945
-197
| -2% | -$5.02K |
|
|
QTS
1302
DELISTED
QTS REALTY TRUST, INC.
QTS
| $263K | ﹤0.01% |
5,390
-2,133
| -28% | -$107K |
|
|
STMP
1303
DELISTED
Stamps.com, Inc.
STMP
| $263K | ﹤0.01% |
2,226
-726
| -25% | -$89.7K |
|
1304
Liberty Latin America Class A
LILA
$1.51B
| $262K | ﹤0.01% |
18,432
-741
| -4% | -$11K |
|
1305
MGE Energy Inc
MGEE
$3.12B
| $262K | ﹤0.01% |
4,028
-1,592
| -28% | -$101K |
|
|
SFBS
1306
ServisFirst Bancshares
SFBS
$4.8B
| $262K | ﹤0.01% |
7,214
-1,592
| -18% | -$62.5K |
|
|
ZEN
1307
DELISTED
ZENDESK INC
ZEN
| $262K | ﹤0.01% |
9,347
-3,695
| -28% | -$95.7K |
|
|
AF
1308
DELISTED
Astoria Financial Corporation
AF
| $261K | ﹤0.01% |
12,720
-4,100
| -24% | -$79.2K |
|
|
ORBC
1309
DELISTED
ORBCOMM, Inc.
ORBC
| $261K | ﹤0.01% |
27,278
-15,204
| -36% | -$130K |
|
|
NVRO
1310
DELISTED
NEVRO CORP.
NVRO
| $259K | ﹤0.01% |
2,765
-1,094
| -28% | -$99.1K |
|
|
NSTG
1311
DELISTED
NanoString Technologies, Inc.
NSTG
| $259K | ﹤0.01% |
13,018
-3,381
| -21% | -$64.3K |
|
|
TLGT
1312
DELISTED
Teligent, Inc
TLGT
| $259K | ﹤0.01% |
3,312
-863
| -21% | -$62.2K |
|
|
KATE
1313
DELISTED
Kate Spade & Company
KATE
| $259K | ﹤0.01% |
11,141
-1,659
| -13% | -$34.7K |
|
1314
Boston Beer
SAM
$1.88B
| $258K | ﹤0.01% |
1,787
-500
| -22% | -$78.3K |
|
|
MACK
1315
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $258K | ﹤0.01% |
10,633
-2,742
| -21% | -$68.6K |
|
1316
Ameris Bancorp
ABCB
$5.89B
| $257K | ﹤0.01% |
5,578
-1,294
| -19% | -$59.2K |
|
1317
Cable One
CABO
$215M
| $257K | ﹤0.01% |
412
-62
| -13% | -$38.8K |
|
|
HAWK
1318
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
| $257K | ﹤0.01% |
6,323
-2,502
| -28% | -$92.8K |
|
1319
Ormat Technologies
ORA
$6.1B
| $256K | ﹤0.01% |
4,478
-1,771
| -28% | -$98.2K |
|
1320
HealthEquity
HQY
$7.91B
| $254K | ﹤0.01% |
5,989
-1,899
| -24% | -$84K |
|
1321
Mercury Systems
MRCY
$6.2B
| $254K | ﹤0.01% |
6,492
-679
| -9% | -$24.1K |
|
1322
RBC Bearings
RBC
$18.9B
| $254K | ﹤0.01% |
2,611
-1,032
| -28% | -$95.7K |
|
|
SFR
1323
DELISTED
Starwood Waypoint Homes
SFR
| $254K | ﹤0.01% |
7,488
-2,959
| -28% | -$94.1K |
|
1324
Bloomin' Brands
BLMN
$681M
| $253K | ﹤0.01% |
12,806
-4,874
| -28% | -$86.8K |
|
1325
Power Integrations
POWI
$3.58B
| $253K | ﹤0.01% |
7,686
-2,422
| -24% | -$80.5K |
|
Similar funds
ProShare Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, ProShare Advisors held 1,755 positions worth $9.56B, up 5.9% from $9.03B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
ProShare Advisors's Q1 2017 filing shows 15 new, 420 increased, 1,119 reduced and 198 closed positions. Its largest new stake was Qiagen: 113,675 shares worth $3.49M. The largest sale was Healthpeak Properties, an estimated $48.2M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.
- ProShare Advisors's largest Q1 2017 buy was Qiagen: 113,675 shares worth $3.49M.
- ProShare Advisors added most to General Dynamics in Q1 2017, an estimated $57.1M increase.
- ProShare Advisors's biggest Q1 2017 reduction was Healthpeak Properties, cutting an estimated $48.2M.
- ProShare Advisors fully exited Clarcor in Q1 2017, selling an estimated $15.4M.
- ProShare Advisors's ten largest holdings make up 14% of its $9.56B portfolio in Q1 2017.
- ProShare Advisors opened 15 new positions and closed 198 in Q1 2017.
- ProShare Advisors's portfolio value rose 5.9% quarter-over-quarter to $9.56B.
Based on ProShare Advisors's 13F filing for Q1 2017, filed 25 Apr 2017.